OxenFree Capital’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Buy
44,096
+140
+0.3% +$11.6K 1.66% 14
2026
Q1
$3.66M Buy
43,956
+2,575
+6% +$215K 1.78% 14
2025
Q4
$3.47M Buy
41,381
+1,945
+5% +$163K 1.82% 16
2025
Q3
$3.31M Buy
39,436
+4,315
+12% +$359K 1.82% 15
2025
Q2
$2.91M Buy
35,121
+5,669
+19% +$461K 1.79% 15
2025
Q1
$2.36M Buy
29,452
+2,586
+10% +$209K 1.8% 15
2024
Q4
$2.16M Buy
26,866
+1,215
+5% +$99.2K 1.62% 16
2024
Q3
$2.15M Buy
25,651
+1,253
+5% +$103K 1.69% 16
2024
Q2
$1.95M Sell
24,398
-1,704
-7% -$135K 1.7% 17
2024
Q1
$2.1M Buy
26,102
+1,968
+8% +$158K 1.92% 14
2023
Q4
$1.96M Buy
+24,134
New +$1.86M 2.02% 14

Other funds holding VCIT

OxenFree Capital's VCIT Position: Q2 2026 in Review

OxenFree Capital increased its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) stake by 0.32% in Q2 2026, buying an estimated $11.6K and bringing the position to 44,096 shares worth $3.61M. The position accounts for 1.66% of the portfolio, ranked #14.

OxenFree Capital first reported a position in VCIT in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.66M in Q1 2026. 664 funds tracked by Wall St. Rank hold VCIT as of Q2 2026.

  • OxenFree Capital held 44,096 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $3.61M as of Q2 2026.
  • OxenFree Capital bought 140 Vanguard Intermediate-Term Corporate Bond ETF shares in Q2 2026, an estimated $11.6K.
  • Vanguard Intermediate-Term Corporate Bond ETF made up 1.66% of OxenFree Capital's portfolio in Q2 2026, its #14 holding.
  • OxenFree Capital first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023 and has held it in 11 quarters since.
  • OxenFree Capital's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $3.66M in Q1 2026.
  • 664 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q2 2026.

Based on OxenFree Capital's 13F filing for Q2 2026, filed 8 Jul 2026.